| Extracellular HMGB1 as a therapeutic target in inflammatory diseases |
33 |
| Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury |
27 |
| Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging |
25 |
| Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis |
24 |
| Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies |
24 |
| Kinin B1 receptors as a therapeutic target for inflammation |
23 |
| Potential roles of tumor-derived exosomes in angiogenesis |
22 |
| CD73 as a potential opportunity for cancer immunotherapy |
21 |
| Mutant ATRX: uncovering a new therapeutic target for glioma |
18 |
| MUC16 as a novel target for cancer therapy |
18 |
| Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy |
17 |
| Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5) |
16 |
| Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders |
15 |
| FOXP3+Treg as a therapeutic target for promoting anti-tumor immunity |
14 |
| The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity |
14 |
| Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells |
14 |
| The COX-2/prostanoid signaling cascades in seizure disorders |
14 |
| Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases |
14 |
| Glucocorticoid-induced TNFR-related gene (GITR) as a therapeutic target for immunotherapy |
13 |
| Targeting SOX2 in anticancer therapy |
12 |
| Long noncoding RNA (lncRNA): a target in neuropathic pain |
12 |
| ATAD2 in cancer: a pharmacologically challenging but tractable target |
11 |
| Aberrant lipid metabolism as a therapeutic target in liver cancer |
11 |
| Let-7 microRNA as a potential therapeutic target with implications for immunotherapy |
11 |
| The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease |
11 |
| The 70-kDa heat shock protein (Hsp70) as a therapeutic target for stroke |
11 |
| TDP-43 post-translational modifications in health and disease |
11 |
| Emerging roles of N- and C-terminally truncated A beta species in Alzheimer's disease |
10 |
| Inducible nitric oxide synthase as a target for osteoarthritis treatment |
10 |
| The potential utility of PFKFB3 as a therapeutic target |
10 |
| The P2X7 receptor: a new therapeutic target in Alzheimer's disease |
10 |
| Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem |
10 |
| BCL6 as a therapeutic target for lymphoma |
9 |
| PLK4: a link between centriole biogenesis and cancer |
9 |
| Alopecia areata and the gut-the link opens up for novel therapeutic interventions |
9 |
| Galectin-3: is this member of a large family of multifunctional lectins (already) a therapeutic target? |
9 |
| Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status |
9 |
| Blockade of TGF-beta signaling: a potential target for cancer immunotherapy? |
9 |
| Current strategies toward safer mu opioid receptor drugs for pain management |
8 |
| Macrophage migration inhibitory Factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus |
8 |
| Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target |
8 |
| MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications |
8 |
| Emerging therapeutic targets for treatment of leishmaniasis |
8 |
| Mitochondrial-derived peptide humanin as therapeutic target in cancer and degenerative diseases |
8 |
| Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies |
8 |
| Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy |
7 |
| Calpain-2 as a therapeutic target for acute neuronal injury |
7 |
| TGF beta as a therapeutic target in cystic fibrosis |
7 |
| The Notch pathway: a novel therapeutic target for cardiovascular diseases? |
7 |
| Adipokines as therapeutic targets in breast cancer treatment |
7 |